Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Mucosal Immunol ; 8(3): 491-504, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25269705

RESUMEN

TRPM8 is the molecular sensor for cold; however, the physiological role of TRPM8+ neurons at mucosal surfaces is unclear. Here we evaluated the distribution and peptidergic properties of TRPM8+ fibers in naive and inflamed colons, as well as their role in mucosal inflammation. We found that Trpm8(-/-) mice were hypersusceptible to dextran sodium sulfate (DSS)-induced colitis, and that Trpm8(-/-) CD11c+ DCs (dendritic cells) showed hyperinflammatory responses to toll-like receptor (TLR) stimulation. This was phenocopied in calcitonin gene-related peptide (CGRP) receptor-deficient mice, but not in substance P receptor-deficient mice, suggesting a functional link between TRPM8 and CGRP. The DSS phenotype of CGRP receptor-deficient mice could be adoptively transferred to wild-type (WT) mice, suggesting that CGRP suppresses the colitogenic activity of bone marrow-derived cells. TRPM8+ mucosal fibers expressed CGRP in human and mouse colon. Furthermore, neuronal CGRP contents were increased in colons from naive and DSS-treated Trpm8(-/-) mice, suggesting deficient CGRP release in the absence of TRPM8 triggering. Finally, treatment of Trpm8(-/-) mice with CGRP reversed their hyperinflammatory phenotype. These results suggest that TRPM8 signaling in mucosal sensory neurons is indispensable for the regulation of innate inflammatory responses via the neuropeptide CGRP.


Asunto(s)
Péptido Relacionado con Gen de Calcitonina/inmunología , Colitis/inmunología , Inmunidad Innata , Mucosa Intestinal/inmunología , Células Receptoras Sensoriales/inmunología , Canales Catiónicos TRPM/inmunología , Animales , Péptido Relacionado con Gen de Calcitonina/deficiencia , Péptido Relacionado con Gen de Calcitonina/genética , Colitis/inducido químicamente , Colitis/genética , Colitis/patología , Colon/inmunología , Colon/patología , Células Dendríticas/inmunología , Células Dendríticas/patología , Sulfato de Dextran , Células Epiteliales/inmunología , Células Epiteliales/patología , Femenino , Regulación de la Expresión Génica , Humanos , Inmunidad Mucosa , Mucosa Intestinal/patología , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados , Fenotipo , Receptores de Neuroquinina-1/deficiencia , Receptores de Neuroquinina-1/genética , Receptores de Neuroquinina-1/inmunología , Células Receptoras Sensoriales/patología , Transducción de Señal , Canales Catiónicos TRPM/deficiencia , Canales Catiónicos TRPM/genética
2.
S Afr Med J ; 103(4 Pt 2): 261-7, 2013 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-23547704

RESUMEN

BACKGROUND: Pharmacological prophylactic anticoagulation in many countries, including South Africa, is under-prescribed. This has resulted in unacceptable rates of morbidity and mortality. METHOD: The Southern African Society of Thrombosis and Haemostasis held a meeting to update the previous guideline and review new literature including guidelines from other societies. The following specialties were represented on the committees: anaesthetics, cardiology, clinical haematology, critical care, obstetrics and gynaecology, haematopathology, internal medicine, neurology, orthopaedic surgery and pulmonology. A draft document was presented at the meeting, which was then revised by consensus agreement. To avoid local bias, the guideline was adjudicated by recognised international external experts. RESULTS AND CONCLUSION: A concise, practical updated guideline for thromboprophylaxis and treatment in medical and surgical patients has been produced for South African conditions. It is hoped that this guideline will continue to improve anticoagulation practice in this country, which we believe will directly benefit patient outcomes.


Asunto(s)
Anticoagulantes , Hemorragia , Cuidados Preoperatorios/métodos , Prevención Secundaria/métodos , Filtros de Vena Cava , Tromboembolia Venosa , Anticoagulantes/administración & dosificación , Anticoagulantes/efectos adversos , Bencimidazoles/administración & dosificación , Bencimidazoles/efectos adversos , Quimioprevención/métodos , Dabigatrán , Manejo de la Enfermedad , Relación Dosis-Respuesta a Droga , Sistemas de Liberación de Medicamentos/métodos , Monitoreo de Drogas/métodos , Sustitución de Medicamentos/métodos , Hemorragia/inducido químicamente , Hemorragia/prevención & control , Hemorragia/terapia , Heparina de Bajo-Peso-Molecular/administración & dosificación , Heparina de Bajo-Peso-Molecular/efectos adversos , Humanos , Relación Normalizada Internacional , Morfolinas/administración & dosificación , Morfolinas/efectos adversos , Medición de Riesgo , Factores de Riesgo , Rivaroxabán , Tiofenos/administración & dosificación , Tiofenos/efectos adversos , Factores de Tiempo , Tromboembolia Venosa/clasificación , Tromboembolia Venosa/diagnóstico , Tromboembolia Venosa/prevención & control , Tromboembolia Venosa/terapia , beta-Alanina/administración & dosificación , beta-Alanina/efectos adversos , beta-Alanina/análogos & derivados
3.
S Afr Med J ; 99(6): 467-8, 470-3, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19736851

RESUMEN

BACKGROUND: Pharmacological prophylactic anticoagulation in many countries, including South Africa, is under-prescribed, which unfortunately results in unacceptable morbidity and mortality in a substantial number of patients. METHOD: The Southern African Society of Thrombosis and Haemostasis reviewed the available literature as well as guidelines from other societies. Specialties represented on the committees included anaesthetics, cardiology, clinical haematology, critical care, gynaecology, haematopathology, internal medicine, neurology, orthopaedic surgery, pulmonology and vascular surgery. A draft document was produced, which was revised by consensus agreement. To avoid local bias, the guidelines were adjudicated by recognised independent international external experts. RESULTS AND CONCLUSION. A concise, practical guideline for thrombo-prophylaxis and treatment in medical and surgical patients has been produced for South African conditions. These guidelines will hopefully lead to improved anticoagulation practice in this country, which we believe will directly benefit patient outcomes.


Asunto(s)
Tromboembolia Venosa/prevención & control , Tromboembolia Venosa/terapia , Anticoagulantes/uso terapéutico , Humanos , Medicina en las Artes , Tromboembolia Venosa/sangre , Tromboembolia Venosa/etiología
4.
Mol Biol Rep ; 27(2): 87-98, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11092555

RESUMEN

The muscle regulatory factors (MRF) gene family regulate muscle fibre development. Several hormones and drugs also affect muscle development. Glucocorticoids are the only drugs reported to have a beneficial effect on muscle degenerative disorders. We investigated the glucocorticoid-related effects on C2C12 myoblast proliferation rate, morphological differentiation, and subsequent mRNA expression patterns of the MRF genes. C2C12 cells were incubated with the glucocorticoids dexamethasone or alpha-methyl-prednisolone. Both glucocorticoids showed comparable effects. Glucocorticoid treatment of C2C12 cells during the proliferative phase reduced the proliferation rate of the cells dose dependently, especially during the third and fourth day of culture, increased MyoD1, myf-5, and MRF4 mRNA levels, and reduced myogenin mRNA level, compared to untreated control cells. Thus, the mRNA level of proliferation-specific MyoD1 and myf-5 expression does not seem to associate with C2C12 myoblast proliferation rate. Glucocorticoid treatment of C2C12 cells during differentiation reduced the differentiation capacity dose dependently, which is accompanied by a dose dependent reduction of myogenin mRNA level, and increased MyoD1, myf-5, and MRF4 mRNA levels compared to untreated control cells. Therefore, we conclude that glucocorticoid treatment reduces differentiation of C2C12 myoblasts probably through reduction of differentiation-specific myogenin mRNA level, while inducing higher mRNA levels of proliferation-associated MRF genes.


Asunto(s)
Proteínas de Unión al ADN , Glucocorticoides/farmacología , Fibras Musculares Esqueléticas/citología , Fibras Musculares Esqueléticas/fisiología , Factores Reguladores Miogénicos/genética , Transactivadores , Animales , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/genética , División Celular/efectos de los fármacos , División Celular/genética , Línea Celular , Dexametasona/farmacología , Relación Dosis-Respuesta a Droga , Regulación de la Expresión Génica/efectos de los fármacos , Metilprednisolona/farmacología , Ratones , Fibras Musculares Esqueléticas/efectos de los fármacos , Proteínas Musculares/efectos de los fármacos , Proteínas Musculares/genética , Proteína MioD/efectos de los fármacos , Proteína MioD/genética , Factor 5 Regulador Miogénico , Factores Reguladores Miogénicos/efectos de los fármacos , Miogenina/efectos de los fármacos , Miogenina/genética , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo
6.
Mol Biol Rep ; 26(4): 277-84, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10634511

RESUMEN

Muscle formation and postnatal growth is under the control of the muscle regulatory factors (MRF) gene family, consisting of four genes: MyoD1, myogenin, myf-5, and myf-6. Muscle mass is also known to be affected by specific drugs, like glucocorticoids. Glucocorticoids have also been characterized as muscle atrophying agents. However, glucocorticoids are also the only drugs reported to have a beneficial effect on the treatment of muscle degenerative disorders. Since muscle mass relates to gender, this may be partially caused by gender. The aim of this study is to investigate gender-related basal and dexamethasone-induced expression of the MRF genes. Gender-specific MRF mRNA levels were investigated in anterior tibial muscles of the rat. Myogenin, myf-5, and myf-6 mRNA level was significantly higher in female rats than in male rats. Since muscle mass is usually higher in males, we conclude that the development of gender-related differences in muscle mass is not primarily under the control of the mRNA levels of the MRF genes. Male rats treated with dexamethasone for 14 days (1 mg per kg body weight) showed increased levels of MyoD1, myogenin and myf-5 compared to control male rats. Female rats treated with dexamethasone showed decreased expression of myf-6 compared to control female rats. These results suggest that dexamethasone increase satellite cell-specific MRF activity in male muscle tissue, which is suggested to be associated with muscle hypertrophy, while maintenance of muscle tissue is affected in female muscle tissue. Therefore, we conclude that both basal and dexamethasone-induced MRF gene mRNA levels are regulated gender-specific.


Asunto(s)
Proteínas de Unión al ADN , Dexametasona/farmacología , Músculo Esquelético/metabolismo , Factores Reguladores Miogénicos/genética , Factores Reguladores Miogénicos/metabolismo , Caracteres Sexuales , Transactivadores , Animales , Femenino , Regulación del Desarrollo de la Expresión Génica , Masculino , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Proteína MioD/genética , Proteína MioD/metabolismo , Factor 5 Regulador Miogénico , Miogenina/genética , Miogenina/metabolismo , ARN Mensajero/metabolismo , Ratas , Tibia
7.
Br J Obstet Gynaecol ; 104(5): 567-71, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9166199

RESUMEN

OBJECTIVE: To assess the maternal and neonatal effects of upright compared with recumbent positions during delivery, in terms of defined outcome variables. DESIGN: A randomised controlled trial. SETTING: St Monica's Nursing Home, a midwife based maternity unit in Cape Town, South Africa. PARTICIPANTS: Five hundred and seventeen women of low obstetrical risk assigned to deliver at the nursing home. RESULTS: The trial showed that women who adopted the upright posture for delivery experienced less pain. perineal trauma and fewer episiotomies than those who delivered in the supine position. CONCLUSION: The data suggest that in women of low obstetrical risk, choice of posture during delivery may be encouraged.


Asunto(s)
Segundo Periodo del Trabajo de Parto , Postura , Adolescente , Adulto , Episiotomía , Femenino , Humanos , Complicaciones del Trabajo de Parto/prevención & control , Dolor/prevención & control , Dimensión del Dolor , Embarazo , Resultado del Embarazo
10.
Clin Exp Obstet Gynecol ; 21(1): 10-3, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-8020170

RESUMEN

Bladder neck suspension operations are commonly performed for stress incontinence. Cure is achieved by increasing proximal urethral pressure by repositioning the bladder neck in a supported retropubic position. A prospective study of 25 consecutive cases assessed the position of the bladder neck radiologically pre- and postoperatively and correlated this with the symptomatic cure or failure of surgery. The final position of the bladder neck relative to the inferior border of the symphysis pubis showed no correlation with the symptomatic outcome. Three cases of "failed" surgery showed greater elevation of the bladder neck than that achieved in women enjoying symptomatic cure, suggesting that the absolute amount of elevation achieved may not be of paramount importance. This report suggests that continence after surgery is not solely related to the anatomical position of the bladder neck relative to the sacral plane, but is more likely due to increased proximal urethral pressure during stress.


Asunto(s)
Vejiga Urinaria/cirugía , Incontinencia Urinaria de Esfuerzo/cirugía , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Estudios Prospectivos , Insuficiencia del Tratamiento , Uretra/anatomía & histología , Uretra/fisiopatología , Vejiga Urinaria/anatomía & histología , Incontinencia Urinaria de Esfuerzo/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...